Soy, Enterolactone, Green Tea May Reduce Adverse Breast Cancer Outcomes
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 23, 2024 -- Soy, enterolactone, and green tea are associated with reductions in adverse breast cancer outcomes, according to a systematic review and meta-analysis published in the February issue of JNCI Cancer Spectrum.
M. Diana van Die, Ph.D., from Western Sydney University in Penrith, Australia, and colleagues reviewed prospective and retrospective observational studies examining the impact of soybean, lignans, cruciferous vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. Data were included from 32 studies.
The researchers found that the risk for recurrence was reduced in association with soy isoflavones (hazard ratio, 0.74), especially among postmenopausal and estrogen receptor-positive survivors (hazard ratios, 0.72 and 0.82, respectively), with the greatest reduction in risk seen at 60 mg/day. The reduction was mainly at 20 to 40 mg/day for mortality outcomes. An inverse association was seen for soy protein and soy products with cancer-specific mortality for estrogen receptor-positive disease (hazard ratio, 0.75). Serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, was inversely associated with cancer-specific mortality and all-cause mortality (hazard ratios, 0.72 and 0.69, respectively). There were no effects observed for cruciferous vegetables. Prediagnostic green tea intake was associated with a reduced risk for recurrence for stage I and II breast cancer (hazard ratio, 0.56).
"To further inform clinical practice, evidence is required on the impact of dietary and supplemental intakes of phytonutrients introduced or substantially increased following diagnosis and treatment," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Text Message Outreach Can Help Increase Mammogram Completion Rates
MONDAY, May 6, 2024 -- Text messaging women after initial outreach for breast cancer screening increases mammogram completion rates, according to a study published online May 6 in...
Aspirin Provides No Benefit for Breast Cancer Recurrence, Survival
FRIDAY, May 3, 2024 -- Among participants with high-risk nonmetastatic breast cancer, daily aspirin use did not improve the risk for breast cancer recurrence or survival in early...
USPSTF Recommends Breast Cancer Screening for Women Aged 40 to 75 Years
TUESDAY, April 30, 2024 -- The U.S. Preventive Services Task Force (USPSTF) recommends breast cancer screening for women aged 40 to 75 years, but evidence is insufficient for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.